USA - NASDAQ:GNTA - US36870W1009 - ADR
ChartMill assigns a Buy % Consensus number of 83% to GNTA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-02-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-05 | EF Hutton | Initiate | Buy |
| 2022-07-25 | HC Wainwright & Co. | Initiate | Buy |
| 2022-01-13 | Maxim Group | Initiate | Buy |
8 analysts have analysed GNTA and the average price target is 21.42 USD. This implies a price increase of 831.3% is expected in the next year compared to the current price of 2.3.
The consensus rating for GENENTA SCIENCE SPA - ADR (GNTA) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering GENENTA SCIENCE SPA - ADR (GNTA) is 8.